We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why Is Dentsply (XRAY) Down 1.3% Since Last Earnings Report?
Read MoreHide Full Article
It has been about a month since the last earnings report for Dentsply International (XRAY - Free Report) . Shares have lost about 1.3% in that time frame, outperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Dentsply due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.
DENTSPLY SIRONA Q3 Earnings Miss Estimates, Consumables Sales Down
DENTSPLY SIRONA reported adjusted earnings per share (EPS) of 38 cents in the third quarter of 2018, missing the Zacks Consensus Estimate by 15.6%. The bottom line also deteriorated significantly by 45.7% from the prior-year quarter number.
Net revenues declined 8% year over year to $928.4 million and fell short of the Zacks Consensus Estimate of $952.8 million. At constant currency (cc), the metric declined 5.9%.
Business Details
Net sales Excluding Precious Metal Content
Net sales, excluding precious metal content, came in at $920.3 million, down 7.9% year over year.
For investors’ notice, DENTSPLY’s precious-metal dental alloy products — used by third parties to construct crown and bridge materials — are subject to certain risks of price fluctuations.
Per management, DENTSPLY’s Healthcare business grew by mid-single digits in the quarter under review.
Technology & Equipment
Per management, Technology & Equipment revenues declined 11.3% year over year in the third quarter. Notably, revenues in the segment totaled $495 million. It was further stated that a significant amount of inventory destocking in the reported quarter led to decrease in revenues.
Consumables
DENTSPLY’s Consumable growth was impacted by a short-term disruption from its distribution infrastructure in Venlo, Netherlands. Consumable revenues declined 3.9% year over year to $433.2 million in the quarter.
Restructuring Plan
DENTSPLY announced a comprehensive plan to accelerate revenue growth, expand margins and simplify its business. The plan includes a restructuring that is anticipated to achieve $200-$225 million in net annual cost savings by 2021 through streamlining the organization and consolidating functions. Furthermore, this strategy is expected to boost the top line by 3-4% and deliver an adjusted operating income margin of 20% by the end of 2020 and 22% by 2022.
Revenues by Geography
Revenues from the United States totaled $328.7 million, which fell 9.6% year over year.
In Europe, revenues declined 9.8% on a year-over-year basis to $3.4.8 million in the third quarter. The downside can be primarily attributed to the revenue shortfall with regards to Venlo and some softness in the equipment markets in Central Europe.
Revenues from the Rest of the World (ROW) also inched down 3.1% to $250.9 million. However, the company foresees high-single digit growth opportunities in Latin America and China.
Margin Analysis
Gross profit in the reported quarter summed $476.1 million, down 14.8% on a year-over-year basis. Gross margin was 51.3%, down 410 basis points (bps).
Excluding precious metal content, gross margin came in at 51.7%, which also contracted 420 bps.
Adjusted operating income totaled $57.6 million, down significantly by 55.1% year over year.
Adjusted operating margin in the quarter was 6.2%, down 650 bps from the year-ago period.
Excluding precious metal content, adjusted operating margin came in at 6.3%, down 660 bps in the third quarter.
Financial Condition
DENTSPLY exited the third quarter with cash and cash equivalents of $233.1 million. Operating cash flow amounted to $126 million in the quarter.
Guidance
For 2018, DENTSPLY anticipates adjusted EPS at or slightly below the low end of the previously announced guided range of $2.00-$2.15 per share. The Zacks Consensus Estimate is pegged at $2.07, above the lower end of the projected range.
The 2018 revenue guidance assumes a decline of 2% at cc. The Zacks Consensus Estimate is pinned at $3.99 billion
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed a downward trend in fresh estimates.
VGM Scores
Currently, Dentsply has an average Growth Score of C, though it is lagging a bit on the Momentum Score front with a D. Following the exact same course, the stock was allocated a grade of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of this revision indicates a downward shift. It's no surprise Dentsply has a Zacks Rank #5 (Strong Sell). We expect a below average return from the stock in the next few months.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Why Is Dentsply (XRAY) Down 1.3% Since Last Earnings Report?
It has been about a month since the last earnings report for Dentsply International (XRAY - Free Report) . Shares have lost about 1.3% in that time frame, outperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Dentsply due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.
DENTSPLY SIRONA Q3 Earnings Miss Estimates, Consumables Sales Down
DENTSPLY SIRONA reported adjusted earnings per share (EPS) of 38 cents in the third quarter of 2018, missing the Zacks Consensus Estimate by 15.6%. The bottom line also deteriorated significantly by 45.7% from the prior-year quarter number.
Net revenues declined 8% year over year to $928.4 million and fell short of the Zacks Consensus Estimate of $952.8 million. At constant currency (cc), the metric declined 5.9%.
Business Details
Net sales Excluding Precious Metal Content
Net sales, excluding precious metal content, came in at $920.3 million, down 7.9% year over year.
For investors’ notice, DENTSPLY’s precious-metal dental alloy products — used by third parties to construct crown and bridge materials — are subject to certain risks of price fluctuations.
Per management, DENTSPLY’s Healthcare business grew by mid-single digits in the quarter under review.
Technology & Equipment
Per management, Technology & Equipment revenues declined 11.3% year over year in the third quarter. Notably, revenues in the segment totaled $495 million. It was further stated that a significant amount of inventory destocking in the reported quarter led to decrease in revenues.
Consumables
DENTSPLY’s Consumable growth was impacted by a short-term disruption from its distribution infrastructure in Venlo, Netherlands. Consumable revenues declined 3.9% year over year to $433.2 million in the quarter.
Restructuring Plan
DENTSPLY announced a comprehensive plan to accelerate revenue growth, expand margins and simplify its business. The plan includes a restructuring that is anticipated to achieve $200-$225 million in net annual cost savings by 2021 through streamlining the organization and consolidating functions. Furthermore, this strategy is expected to boost the top line by 3-4% and deliver an adjusted operating income margin of 20% by the end of 2020 and 22% by 2022.
Revenues by Geography
Revenues from the United States totaled $328.7 million, which fell 9.6% year over year.
In Europe, revenues declined 9.8% on a year-over-year basis to $3.4.8 million in the third quarter. The downside can be primarily attributed to the revenue shortfall with regards to Venlo and some softness in the equipment markets in Central Europe.
Revenues from the Rest of the World (ROW) also inched down 3.1% to $250.9 million. However, the company foresees high-single digit growth opportunities in Latin America and China.
Margin Analysis
Gross profit in the reported quarter summed $476.1 million, down 14.8% on a year-over-year basis. Gross margin was 51.3%, down 410 basis points (bps).
Excluding precious metal content, gross margin came in at 51.7%, which also contracted 420 bps.
Adjusted operating income totaled $57.6 million, down significantly by 55.1% year over year.
Adjusted operating margin in the quarter was 6.2%, down 650 bps from the year-ago period.
Excluding precious metal content, adjusted operating margin came in at 6.3%, down 660 bps in the third quarter.
Financial Condition
DENTSPLY exited the third quarter with cash and cash equivalents of $233.1 million. Operating cash flow amounted to $126 million in the quarter.
Guidance
For 2018, DENTSPLY anticipates adjusted EPS at or slightly below the low end of the previously announced guided range of $2.00-$2.15 per share. The Zacks Consensus Estimate is pegged at $2.07, above the lower end of the projected range.
The 2018 revenue guidance assumes a decline of 2% at cc. The Zacks Consensus Estimate is pinned at $3.99 billion
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed a downward trend in fresh estimates.
VGM Scores
Currently, Dentsply has an average Growth Score of C, though it is lagging a bit on the Momentum Score front with a D. Following the exact same course, the stock was allocated a grade of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of this revision indicates a downward shift. It's no surprise Dentsply has a Zacks Rank #5 (Strong Sell). We expect a below average return from the stock in the next few months.